Recursion Phar­ma­ceu­ti­cals

Using its digital biology platform, Recursion is building a pipeline of drug candidates for diseases that don’t have approved therapies. At its foundation, the platform uses lab robotics and machine vision to capture changes in the morphology of cells as they’re exposed to toxins, pathogens, genetic changes, and small and large molecules. By pairing this phenomics data with large tran­scrip­tomic and proteomic datasets — and running other custom assays and animal studies — Recursion learns how drug candidates act on cells, and can advance the most promising candidates to clinical trials.